|
gptkbp:instanceOf
|
gptkb:disease
|
|
gptkbp:affects
|
animals
humans
|
|
gptkbp:affectsChildrenMost
|
yes
|
|
gptkbp:affectsPregnantWomen
|
yes
|
|
gptkbp:alsoKnownAs
|
paludism
|
|
gptkbp:annualDeaths
|
over 600,000
|
|
gptkbp:antibioticResistance
|
yes
|
|
gptkbp:canBeFatal
|
yes
|
|
gptkbp:canCauseComplications
|
gptkb:anemia
organ failure
cerebral malaria
|
|
gptkbp:causedBy
|
gptkb:Plasmodium_knowlesi
gptkb:Plasmodium_malariae
gptkb:Plasmodium_ovale
gptkb:Plasmodium_vivax
gptkb:Plasmodium_falciparum
Plasmodium parasite
|
|
gptkbp:commonIn
|
gptkb:Central_America
gptkb:South_America
gptkb:South_Asia
gptkb:sub-Saharan_Africa
|
|
gptkbp:diagnosedBy
|
blood test
|
|
gptkbp:drugResistanceObservedIn
|
gptkb:Plasmodium_falciparum
|
|
gptkbp:firstDescribed
|
gptkb:Charles_Louis_Alphonse_Laveran
1880
|
|
gptkbp:firstVaccineName
|
gptkb:RTS,S/AS01
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
La Malaria
|
|
gptkbp:incubationPeriod
|
7-30 days
|
|
gptkbp:notifiableDisease
|
yes
|
|
gptkbp:numberOfCases
|
over 200 million
|
|
gptkbp:prevention
|
antimalarial drugs
insect repellents
mosquito nets
|
|
gptkbp:studiedBy
|
gptkb:Centers_for_Disease_Control_and_Prevention
gptkb:World_Health_Organization
gptkb:Malaria_Vaccine_Initiative
gptkb:Bill_&_Melinda_Gates_Foundation
|
|
gptkbp:symptom
|
fever
nausea
vomiting
fatigue
headache
muscle pain
sweating
chills
|
|
gptkbp:transmittedBy
|
gptkb:Anopheles_mosquito
|
|
gptkbp:treatment
|
antimalarial drugs
|
|
gptkbp:vaccineAvailable
|
yes
|
|
gptkbp:vectorFor
|
insecticide-treated nets
indoor residual spraying
|
|
gptkbp:WHORecognized
|
yes
|
|
gptkbp:bfsParent
|
gptkb:Ernest_Hébert
|
|
gptkbp:bfsLayer
|
7
|